Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02100345|
Recruitment Status : Completed
First Posted : March 31, 2014
Last Update Posted : May 9, 2017
Background: Endometriosis is a disease affecting 8-15 % of fertile women and is a cause of abdominal pain and suffering during women's menstrual periods. A subgroup of patients with DIE has an infiltration into the rectosigmoid bowel wall (4-37%). Knowledge of the growth pattern of rectosigmoid lesions related to subjective symptoms is mandatory in order to assess the need for follow-up with transvaginal ultrasound during medical treatment.
Symptoms will follow growth of rectosigmoid endometriosis.
Material and methods:
Two different cohorts of women, based on time of diagnosis of rectosigmoid endometriosis and treatment with hormonal intrauterine device or continuous oral contraceptives will receive a questionnaire and a transvaginal ultrasound scan (measuring size and volume) at inclusion, (6) and 12 months later.
Patients treated conservatively may be followed by questionnaires, thereby reducing the need for time consuming clinical controls.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||98 participants|
|Official Title:||Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound|
|Actual Study Start Date :||October 2014|
|Actual Primary Completion Date :||February 2017|
|Actual Study Completion Date :||February 2017|
- Transvaginal Ultrasound [ Time Frame: 29 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02100345
|Aarhus University Hospital|
|Aarhus N, Region Midt, Denmark, 8200|
|Study Director:||Mikkel Mr Seyer-Hansen, MD, PhD||Department of Obstetrics and Gynecology, Aarhus University Hospital|